The pro- or anti-apoptotic function of NF-κB is determined by the nature of the apoptotic stimulus

European Journal of Biochemistry

Volumn 267, Issue 12, 2000, Pages 3828-3835

  Kaltschmidt, Barbara ^a   Kaltschmidt, Christian ^a   Hofmann, Thomas G ^b   Hehner, Steffen P ^b   Dröge, Wulf ^b   Schmitz, M Lienhard ^b  

^a UNIVERSITY OF FREIBURG   (Germany)

^b GERMAN CANCER RESEARCH CENTER DKFZ   (Germany)

Author keywords

Apoptosis; Cancer therapy; NF B; TNF

Indexed keywords

DNA BINDING PROTEIN; HYDROGEN PEROXIDE; IMMUNOGLOBULIN ENHANCER BINDING PROTEIN; IMMUNOGLOBULIN KAPPA CHAIN; PERVANADATE; RECOMBINANT TUMOR NECROSIS FACTOR ALPHA;

APOPTOSIS; ARTICLE; CANCER ADJUVANT THERAPY; CELL KILLING; CELL STIMULATION; CELL SURVIVAL; CONTROLLED STUDY; CYTOTOXICITY; HELA CELL; HUMAN; HUMAN CELL; PRIORITY JOURNAL; SIGNAL TRANSDUCTION; SUPERNATANT;

APOPTOSIS; CASPASE 3; CASPASES; ENZYME ACTIVATION; HELA CELLS; HUMANS; HYDROGEN PEROXIDE; I-KAPPA B PROTEINS; INTERLEUKIN-6; NF-KAPPA B; TRANSFECTION; TUMOR NECROSIS FACTOR-ALPHA; VANADATES;

EID: 0033947601     PISSN: 00142956     EISSN: None     Source Type: Journal    
DOI: 10.1046/j.1432-1327.2000.01421.x     Document Type: Article

References (39)

1. 1. Ghosh, S., May, M.J. & Kopp, E.B. (1998) NF-κB and Rel proteins: evolutionarily conserved mediators of immune responses. Annu. Rev. Immunol. 16, 225-260.
2. 2. Baldwin, A.S. Jr (1996) The NF-κB and IκB proteins: new discoveries and insights. Annu. Rev. Immunol. 14, 649-683.
3. 3. Yaron, A., Hatzubai, A., Davis, M., Lavon, I., Amit, S., Manning, A.M., Andersen, J.S., Mann, M., Mercurio, F. & Ben-Neriah, Y. (1998) Identification of the receptor component of the IκBα-ubiquitin ligase. Nature 396, 590-594.
4. 4. Bender, K., Göttlicher, M., Whiteside, S., Rahmsdorf, H.J. & Herrlich, P. (1998) Sequential DNA damage-independent and -dependent activation of NF-κB by UV. EMBO J. 17, 5170-5181.
5. 5. Li, N. & Karin, M. (1998) Ionizing radiation and short wavelength UV activate NF-κB through two distinct mechanisms. Proc. Natl Acad. Sci. USA 95, 13012-13017.
6. 6. Beraud, C., Henzel, W.J. & Baeuerle, P.A. (1999) Involvement of regulatory and catalytic subunits of phosphoinositide 3-kinase in NF-κB activation. Proc. Natl Acad. Sci. USA 96, 429-434.
7. 7. Hinz, M., Krappmann, D., Eichten, A., Heder, A., Scheidereit, C. & Strauss, M. (1999) NF-κB function in growth control: regulation of cyclin D1 expression and G0/G1-to-S-phase transition. Mol. Cell. Biol. 19, 2690-2698.
8. 8. Kaltschmidt, B., Kaltschmidt, C., Hehner, S.P., Dröge, W. & Schmitz, M.L. (1999) Repression of NF-κB impairs HeLa cell proliferation by functional interference with cell cycle checkpoint regulators. Oncogene 18, 3213-3225.
9. 9. Baichwal, V.R. & Baeuerle, P.A. (1997) Activate NF-κB or die? Curr. Biol. 7, R94-R96.
10. 10. Beg, A.A. & Baltimore, D. (1996) An essential role for NF-κB in preventing TNF-α-induced cell death. Science 274, 782-784.
11. 11. Liu, Z.-G., Hsu, H., Goeddel, D.V. & Karin, M. (1996) Dissection of TNF receptor 1 effector functions: JNK activation is not linked to apoptosis while NF-κB activation prevents cell death. Cell 87, 565-576.
12. 12. Van Antwerp, D.J., Martin, S.J., Kafri, T., Green, D.R. & Verma, I.M. (1996) Suppression of TNF-α-induced apoptosis by NF-κB. Science 274, 787-789.
13. 13. Wang, C.Y., Mayo, M.W. & Baldwin, A.S. Jr (1996) TNF-and cancer therapy-induced apoptosis: potentiation by inhibition of NF-κB. Science 274, 784-787.
14. 14. Wang, C.Y., Cusack, J.C. Jr, Liu, R. & Baldwin, A.S. Jr (1999) Control of inducible chemoresistance: enhanced anti-tumor therapy through increased apoptosis by inhibition of NF-κB. Nat. Med. 5, 412-417.
15. 15. Mayo, M.W., Wang, C.Y., Cogswell, P.C., Rogers, G.K., Lowe, S.W., Der, C.J. & Baldwin, A.S. Jr (1997) Requirement of NF-κB activation to suppress p53-independent apoptosis induced by oncogenic Ras. Science 278, 1812-1815.
16. 16. Hettmann, T., DiDonato, J., Karin, M. & Leiden, J.M. (1999) An essential role for nuclear factor κB in promoting double positive thymocyte apoptosis. J. Exp. Med. 189, 145-158.
17. 17. Grimm, S., Bauer, M.K., Baeuerle, P.A. & Schulze-Osthoff, K. (1996) Bcl-2 down-regulates the activity of transcription factor NF-κB induced upon apoptosis. J. Cell Biol. 134, 13-23.
18. 18. Hehner, S.P., Heinrich, M., Bork, P.M., Vogt, M., Ratter, F., Lehmann, V., Schulze-Osthoff, K., Dröge, W. & Schmitz, M.L. (1998) Sesquiterpene lactones specifically inhibit activation of NF-κB by preventing the degradation of IκB-α and IκB-β. J. Biol. Chem. 273, 1288-1298.
19. 19. Kaltschmidt, B., Uherek, M., Volk, B., Baeuerle, P.A. & Kaltschmidt, C. (1997) Transcription factor NF-κB is activated in primary neurons by amyloid β peptides and in neurons surrounding early plaques from patients with Alzheimer disease. Proc. Natl Acad. Sci. USA 94, 2642-2647.
20. 20. Nicoletti, I., Migliorati, G., Pagliacci, M.C., Grignani, F. & Riccardi, C. (1991) A rapid and simple method for measuring thymocyte apoptosis by propidium iodide staining and flow cytometry. J. Immunol. Method. 139, 271-279.
21. 21. Schmitz, M.L., Indorf, A., Limbourg, F.P., Staedler, H., Traenckner, E.B.-M. & Baeuerle, P.A. (1996) The dual effect of adenovirus type 5 E1A 13S protein on NF-κB activation is antagonized by E1B 19 K. Mol. Cell. Biol. 16, 4052-4063.
22. 22. Dumont, A., Hehner, S.P., Hofmann, T.G., Ueffing, M., Dröge, W. & Schmitz, M.L. (1999) Hydrogen peroxide-induced apoptosis is CD95-independent, requires the release of mitochondria-derived reactive oxygen species and the activation of NF-κB. Oncogene 18, 747-759.
23. 23. Hehner, S.P., Hofmann, T.G., Dröge, W. & Schmitz, M.L. (1999) Inhibition of tyrosine phosphatases induces apoptosis independent from the CD95 system. Cell Death Differ. 6, 833-841.
24. 24. Hehner, S.P., Hofmann, T.G., Dröge, W. & Schmitz, M.L. (1999) The antiinflammatory sesquiterpene lactone parthenolide inhibits NF-κB by targeting the IκB kinase complex. J. Immunol. 163, 5617-5623.
25. 25. Cryns, V. & Yuan, J. (1998) Proteases to die for. Genes Dev. 12, 1551-1570.
26. 26. Vercammen, D., Beyaert, R., Denecker, G., Goossens, V., Van Loo, G., Declercq, W., Grooten, J., Fiers, W. & Vandenabeele, P. (1998) Inhibition of caspases increases the sensitivity of L929 cells to necrosis mediated by tumor necrosis factor. J. Exp. Med. 187, 1477-1485.
27. 27. Berndt, C., Möpps, B., Angermüller, S., Gierschik, P. & Krammer, P.H. (1998) CXCR4 and CD4 mediate a rapid CD95-independent cell death in CD4(+) T cells. Proc. Natl Acad. Sci. USA 95, 12556-12561.
28. 28. Déas, O., Dumont, C., MacFarlane, M., Rouleau, M., Hebib, C., Harper, F., Hirsch, F., Charpentier, B., Cohen, G.M. & Senik, A. (1998) Caspase-independent cell death induced by anti-CD2 or staurosporine in activated human peripheral T lymphocytes. J. Immunol. 161, 3375-3383.
29. 29. Kawahara, A., Ohsawa, Y., Matsumura, H., Uchiyama, Y. & Nagata, S. (1998) Caspase-independent cell killing by Fas-associated protein with death domain. J. Cell Biol. 143, 1353-1360.
30. 30. Xu, F.H., Sharma, S., Gardner, A., Tu, Y., Raitano, A., Sawyers, C. & Lichtenstein, A. (1998) Interleukin-6-induced inhibition of multiple myeloma cell apoptosis: support for the hypothesis that protection is mediated via inhibition of the JNK/SAPK pathway. Blood 92, 241-251.
31. 31. Vanden Berghe, W., De Bosscher, K., Boone, E., Plaisance, S. & Haegeman, G. (1999) The nuclear factor-κB engages CBP/p300 and histone acetyltransferase activity for transcriptional activation of the interleukin-6 gene promoter. J. Biol. Chem. 274, 32091-32098.
32. 32. Wu, M., Lee, H., Bellas, R.E., Schauer, S.L., Arsura, M., Katz, D., FitzGerald, M.J., Rothstein, T.L., Sherr, D.H. & Sonenshein, G.E. (1996) Inhibition of NF-κB/Rel induces apoptosis of murine B cells. EMBO J. 15, 4682-4690.
33. 33. Abbadie, C., Kabrun, N., Bouali, F., Smardova, J., Stehelin, D., Vandenbunder, B. & Enrietto, P.J. (1993) High levels of c-rel expression are associated with programmed cell death in the developing avian embryo and in bone marrow cells in vitro. Cell 5, 899-912.
34. 34. Franzoso, G., Carlson, L., Xing, L., Poljak, L., Shores, E.W., Brown, K.D., Leonardi, A., Tran, T., Boyce, B.F. & Siebenlist, U. (1997) Requirement for NF-κB in osteoclast and B-cell development. Genes Dev. 11, 3482-3496.
35. 35. Bash, J., Zong, W.-X. & Gelinas, C. (1997) c-Rel arrests the proliferation of HeLa cells and affects critical regulators of the G1/S-phase transition. Mol. Cell. Biol. 17, 6526-6536.
36. 36. Natoli, G., Costanzo, A., Guido, F., Moretti, F., Bernardo, A., Burgio, V.L., Agresti, C. & Levrero, M. (1998) Nuclear factor κB-independent cytoprotective pathways originating at tumor necrosis factor receptor-associated factor 2. J. Biol. Chem. 273, 31262-31272.
37. 37. Grumont, R.J., Rourke, I.J. & Gerondakis, S. (1999) Rel-dependent induction of A1 transcription is required to protect B cells from antigen receptor ligation-induced apoptosis. Genes Dev. 13, 400-411.
38. 38. Zong, W.X., Edelstein, L.C., Chen, C., Bash, J. & Gelinas, C. (1999) The prosurvival bcl-2 homolog bfl-1/A1 is a direct transcriptional target of NF-κB that blocks TNFα-induced apoptosis. Genes Dev. 13, 382-387.
39. 39. Ravi, R., Bedi, A., Fuchs, E.J. & Bedi, A. (1998) CD95 (Fas)-induced caspase-mediated proteolysis of NF-κB. Cancer Res. 58, 882-886.